UCB to acquire Neurona Therapeutics for up to $1.15 billion
UCB (Euronext Brussels: UCB) announced it has entered into a definitive agreement to acquire Neurona Therapeutics, a clinical-stage biotherapeutics company ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
